APEN News and Press, Apollo Endosurgery Inc. From 07/19/19

Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release its financial results for the first quarter ended June 30, 2019 on Tuesday,...

Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that the final patient has been enrolled in the Multi-Center ESG Randomized Interventional Trial (MERIT). The US based, pro...

Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today that company management is scheduled to present at the JMP Securities 2019 Life Sciences Conference being held June...

Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures announced today that it has received FDA approval for its proposed labeling updates for the ORBERA® Intragastric Balloon System...

It's sometime ago since we looked at Apollo Endosurgery ( APEN ), and the progress we expected hasn't really materialized. Data by YCharts The company divested its surgical systems (the Lap Band) in Q4 of last year to concentrate on its non-surgical products, which are: ESS Endosco...

Soliton ( SOLY ) had a recent Reg A+ IPO in February 2019, with an unproven device that is supposed to assist a laser with tattoo and cellulite removal. SOLY is a relentless PR machine that we believe will end very badly for shareholders who think they are holding a solid investment. The compa...

Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today its participation during Digestive Disease Week 2019 (“DDW”). DDW will be held May 18-21, 2019 at th...

Apollo Endosurgery, Inc. (APEN) Q1 2019 Earnings Conference Call May 02, 2019 04:30 PM ET Company Participants John Gillings - Investors Relations Todd Newton - Chief Executive Officer Stefanie Cavanaugh - Chief Financial Officer Conference Call Participants Matt Hewitt - C...

Apollo Endosurgery (NASDAQ: APEN ): Q1 GAAP EPS of -$0.13 beats by $0.23 . More news on: Apollo Endosurgery, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced financial results for the first quarter ended Mar...